Showing results (841-850 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|March 14, 2014
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trialAgnès Hartemann, Gilbert Bensimon, Christine A Payan, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trialStephen E Gitelman, Peter A Gottlieb, Mark R Rigby, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolomeLee D Roberts, Albert Koulman, Julian L Griffin
The Lancet. Diabetes & Endocrinology|March 14, 2014
Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control studyCarlo B Giorda, Roberta Picariello, Elisa Nada, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trialDavid Preiss, Suzanne M Lloyd, Ian Ford, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysisKirstine J Bell, Alan W Barclay, Peter Petocz, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Bone loss after bariatric surgery: causes, consequences, and managementEmily M Stein, Shonni J Silverberg
The Lancet. Diabetes & Endocrinology|March 14, 2014
Diabetes drugs and neurological disorders: new views and therapeutic possibilitiesCesare Patrone, Ove Eriksson, Dan Lindholm
The Lancet. Diabetes & Endocrinology|April 8, 2014
Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation studyShoaib Afzal, Peter Brøndum-Jacobsen, Stig E Bojesen, et al.
The Lancet. Diabetes & Endocrinology|April 8, 2014
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysisMark J Bolland, Andrew Grey, Greg D Gamble, et al.
Pageof 93